C45H46N12O4 — CID 136999857
4-(1-cyclohexylbenzimidazol-5-yl)-N-[[(3S)-1-[7-(1-cyclohexylbenzimidazol-5-yl)-4-nitro-1H-benzimidazol-5-yl]pyrrolidin-3-yl]-hydroxymethyl]-3H-imidazo[4,5-c]pyridine-7-carboxamide (PubChem CID 136999857) has the molecular formula C45H46N12O4 and a molecular weight of 818.94 g/mol. Its IUPAC name is 4-(1-cyclohexylbenzimidazol-5-yl)-N-[[(3S)-1-[7-(1-cyclohexylbenzimidazol-5-yl)-4-nitro-1H-benzimidazol-5-yl]pyrrolidin-3-yl]-hydroxymethyl]-3H-imidazo[4,5-c]pyridine-7-carboxamide.
| Compound Name | 4-(1-cyclohexylbenzimidazol-5-yl)-N-[[(3S)-1-[7-(1-cyclohexylbenzimidazol-5-yl)-4-nitro-1H-benzimidazol-5-yl]pyrrolidin-3-yl]-hydroxymethyl]-3H-imidazo[4,5-c]pyridine-7-carboxamide |
|---|---|
| PubChem CID | 136999857 |
| Molecular Formula | C45H46N12O4 |
| Molecular Weight | 818.94 g/mol |
| Exact Mass | 818.38 |
| IUPAC Name | 4-(1-cyclohexylbenzimidazol-5-yl)-N-[[(3S)-1-[7-(1-cyclohexylbenzimidazol-5-yl)-4-nitro-1H-benzimidazol-5-yl]pyrrolidin-3-yl]-hydroxymethyl]-3H-imidazo[4,5-c]pyridine-7-carboxamide |
| SMILES | O=C(NC(O)[C@H]1CCN(c2cc(-c3ccc4c(c3)ncn4C3CCCCC3)c3[nH]cnc3c2[N+](=O)[O-])C1)c1cnc(-c2ccc3c(c2)ncn3C2CCCCC2)c2[nH]cnc12 |
| InChI | InChI=1S/C45H46N12O4/c58-44(53-45(59)32-20-46-38(41-40(32)48-22-49-41)27-12-14-36-34(18-27)52-25-56(36)30-9-5-2-6-10-30)28-15-16-54(21-28)37-19-31(39-42(50-23-47-39)43(37)57(60)61)26-11-13-35-33(17-26)51-24-55(35)29-7-3-1-4-8-29/h11-14,17-20,22-25,28-30,44,58H,1-10,15-16,21H2,(H,47,50)(H,48,49)(H,53,59)/t28-,44?/m0/s1 |
| InChIKey | LGRNHPLEFLMTBK-DNAUWEQISA-N |
| XLogP | 8.36 |
| TPSA | 201.60 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 61 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 818.94 |
| LogP ≤ 5 | 8.36 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|